Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS-associated Kaposi's sarcoma: a molecular model for its pathogenesis.

B Ensoli1, S Z Salahuddin, R C Gallo

  • 1Laboratory of Tumor Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892.

Cancer Cells (Cold Spring Harbor, N.Y. : 1989)
|November 1, 1989
PubMed
Summary

Kaposi's sarcoma, a tumor common in AIDS patients, is linked to HIV-1 infection. This study explores how cytokines and the HIV tat protein may contribute to its development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017-2019 multicenter cross-sectional study.

Scientific reports·2023
Same author

Induction of antibodies and T cell responses by a recombinant influenza virus carrying an HIV-1 TatΔ51-59 protein in mice.

BioMed research international·2014
Same author

Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cy.

Tissue antigens·2012
Same author

Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate.

Reviews on recent clinical trials·2009
Same author

Primary effusion lymphoma cells undergoing human herpesvirus type 8 productive infection produce C-type retroviral particles.

International journal of immunopathology and pharmacology·2009
Same author

Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.

Vaccine·2008

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Kaposi's sarcoma (KS) is a mesenchymal tumor frequently diagnosed in individuals with Acquired Immunodeficiency Syndrome (AIDS).
  • While KS is strongly associated with Human Immunodeficiency Virus type 1 (HIV-1) infection, the specific molecular mechanisms driving its pathogenesis remain largely unclear.
  • Understanding these mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the potential roles of specific cytokines in the development of Kaposi's sarcoma.
  • To examine the contribution of the virally encoded tat protein of HIV-1 to Kaposi's sarcoma pathogenesis.
  • To elucidate molecular pathways involved in KS development in the context of HIV-1 infection.

Main Methods:

  • Review of existing literature on KS pathogenesis.

Related Experiment Videos

  • Analysis of the known functions of specific cytokines in cellular proliferation and angiogenesis.
  • Examination of the biological activities of the HIV-1 tat protein, including its potential oncogenic properties.

    • Main Results:

    • Certain cytokines may promote the uncontrolled cellular growth and blood vessel formation characteristic of KS.
    • The HIV-1 tat protein may possess oncogenic capabilities, potentially contributing to KS development.
    • A complex interplay between host immune responses, viral factors, and specific cytokines likely drives KS pathogenesis.

    Conclusions:

    • Cytokines and the HIV-1 tat protein are plausible contributors to Kaposi's sarcoma development.
    • Further research is needed to fully delineate the molecular interactions driving KS.
    • Identifying key molecular players could lead to novel therapeutic strategies for KS in HIV-1-infected individuals.